{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "CIN, infection risk, thrombosis risk",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "CIN, infection risk, thrombosis risk",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "CIN, infection risk, thrombosis risk",
            "expectation": "若风险成立，标注高权重 refutes 边",
            "assignee": "Skeptic"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_c5_inhibitors",
          "type": "Drug",
          "label": "C5 Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_complement_inhibitors",
          "type": "Drug",
          "label": "Complement Inhibitors",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_fostamatinib",
          "type": "Drug",
          "label": "Fostamatinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_luspatercept",
          "type": "Drug",
          "label": "Luspatercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexamethasone",
          "type": "Drug",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tacrolimus",
          "type": "Drug",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_aHUS",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_risk_cin",
          "type": "Phenotype",
          "label": "CIN (Contrast-Induced Nephropathy)",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_infection",
          "type": "Phenotype",
          "label": "Infection Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_risk_thrombosis",
          "type": "Phenotype",
          "label": "Thrombosis Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_c5_inhibitor",
          "type": "Target",
          "label": "C5 Inhibitor Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_complement_inhibition",
          "type": "Target",
          "label": "Complement System Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cin_mechanism",
          "type": "Pathway",
          "label": "CIN Mechanism Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infection_mechanism",
          "type": "Pathway",
          "label": "Infection Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_thrombosis_mechanism",
          "type": "Pathway",
          "label": "Thrombosis Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Eculizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "C5 Inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Complement Inhibitors",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Fostamatinib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Luspatercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Dexamethasone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Tacrolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_eculizumab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "已知对aHUS的有效性"
        },
        {
          "source": "drug_ravulizumab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与Eculizumab相似的机制"
        },
        {
          "source": "drug_c5_inhibitors",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "同类药物作用于同一个靶点"
        },
        {
          "source": "drug_complement_inhibitors",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "补体途径相关性"
        },
        {
          "source": "drug_fostamatinib",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "治疗效果相关的文献"
        },
        {
          "source": "drug_luspatercept",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "新兴疗法潜力"
        },
        {
          "source": "drug_dexamethasone",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫调节作用"
        },
        {
          "source": "drug_cyclosporine",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "临床用药背景"
        },
        {
          "source": "drug_tacrolimus",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "相关机制推测"
        },
        {
          "source": "drug_sirolimus",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "可考虑作为辅助疗法"
        },
        {
          "source": "drug_rituximab",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "针对免疫性异常的作用"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "disease_aHUS",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "用于症状管理的潜力"
        },
        {
          "source": "drug_eculizumab",
          "target": "n_ot_c5_inhibitor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可导致非特异性靶向效应"
        },
        {
          "source": "drug_ravulizumab",
          "target": "n_ot_c5_inhibitor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能引发旁路作用"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_cin_mechanism",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与 CIN 机制相关"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_infection_mechanism",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "可能增加感染风险"
        },
        {
          "source": "n_ot_c5_inhibitor",
          "target": "n_ot_thrombosis_mechanism",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Skeptic",
          "rationale": "与血栓形成机制相关"
        },
        {
          "source": "n_ot_cin_mechanism",
          "target": "n_risk_cin",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "潜在的 CIN 风险"
        },
        {
          "source": "n_ot_infection_mechanism",
          "target": "n_risk_infection",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "提高感染风险"
        },
        {
          "source": "n_ot_thrombosis_mechanism",
          "target": "n_risk_thrombosis",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致血栓风险"
        },
        {
          "source": "n_risk_cin",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "以上风险影响 Eculizumab 的效果"
        },
        {
          "source": "n_risk_infection",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "感染风险与治疗效果相悖"
        },
        {
          "source": "n_risk_thrombosis",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "血栓风险与合并症相悖"
        }
      ],
      "round_index": 3
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [
            {
              "id": "n_ot_c5_inhibitor",
              "type": "Target",
              "label": "C5 Inhibitor Off-Target Effects",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_complement_inhibition",
              "type": "Target",
              "label": "Complement System Effects",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_cin_mechanism",
              "type": "Pathway",
              "label": "CIN Mechanism Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_infection_mechanism",
              "type": "Pathway",
              "label": "Infection Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            },
            {
              "id": "n_ot_thrombosis_mechanism",
              "type": "Pathway",
              "label": "Thrombosis Pathway",
              "attrs": {
                "agent": "Skeptic"
              }
            }
          ],
          "add_edges": [
            {
              "source": "drug_eculizumab",
              "target": "n_ot_c5_inhibitor",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "可导致非特异性靶向效应"
            },
            {
              "source": "drug_ravulizumab",
              "target": "n_ot_c5_inhibitor",
              "relation": "acts_on",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "可能引发旁路作用"
            },
            {
              "source": "n_ot_c5_inhibitor",
              "target": "n_ot_cin_mechanism",
              "relation": "involved_in",
              "weight": 0.7,
              "agent": "Skeptic",
              "rationale": "与 CIN 机制相关"
            },
            {
              "source": "n_ot_c5_inhibitor",
              "target": "n_ot_infection_mechanism",
              "relation": "involved_in",
              "weight": 0.6,
              "agent": "Skeptic",
              "rationale": "可能增加感染风险"
            },
            {
              "source": "n_ot_c5_inhibitor",
              "target": "n_ot_thrombosis_mechanism",
              "relation": "involved_in",
              "weight": 0.6,
              "agent": "Skeptic",
              "rationale": "与血栓形成机制相关"
            },
            {
              "source": "n_ot_cin_mechanism",
              "target": "n_risk_cin",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "潜在的 CIN 风险"
            },
            {
              "source": "n_ot_infection_mechanism",
              "target": "n_risk_infection",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "提高感染风险"
            },
            {
              "source": "n_ot_thrombosis_mechanism",
              "target": "n_risk_thrombosis",
              "relation": "causes",
              "weight": 0.8,
              "agent": "Skeptic",
              "rationale": "可能导致血栓风险"
            },
            {
              "source": "n_risk_cin",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "以上风险影响 Eculizumab 的效果"
            },
            {
              "source": "n_risk_infection",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "感染风险与治疗效果相悖"
            },
            {
              "source": "n_risk_thrombosis",
              "target": "H1",
              "relation": "refutes",
              "weight": 0.9,
              "agent": "Skeptic",
              "rationale": "血栓风险与合并症相悖"
            }
          ],
          "conflict_hotspots": [
            {
              "topic": "CIN, infection risk, thrombosis risk",
              "pro_nodes": [],
              "con_nodes": [
                "n_risk_cin",
                "n_risk_infection",
                "n_risk_thrombosis"
              ],
              "note": "风险与期望疗效之间存在明显矛盾"
            }
          ]
        },
        "notes": "已完成安全性压力测试：以高权重 refutes 边连到假设"
      }
    ],
    "unexecuted_actions": [],
    "residual_conflicts": [
      "各类风险的潜在影响未完全消解",
      "缺乏对长期效果的具体数据支持"
    ]
  }
}